Literature DB >> 11082515

Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.

F Zipp1, C Windemuth, H Pankow, J Dichgans, T Wienker, R Martin, C Müller.   

Abstract

Among the candidate genes for multiple sclerosis (MS), the strongest influence is conferred by human leucocyte antigen (HLA) class II genes, in particular the DR2, DQ6, Dw2 haplotype (DRB1*1501, DQA1*0102, DQB1*0602). Similar to other autoimmune diseases, it is not clear yet how the presence of a specific HLA-DR or -DQ molecule translates into an increased disease susceptibility. Previous observations by us and others imply a HLA-DR2 dependent propensity of antigen-specific T-cell lines to produce increased amounts of TNF-alpha/beta as one mechanism how DR2 could contribute to susceptibility. In this article, we investigated the distribution of polymorphic stretches of the DRB1, DQA1, and DQB1 chains known to be relevant for antigen binding, in 66 unrelated patients with relapsing remitting MS and 210 unrelated controls. We found a significant association with disease for the appearance of proline at position 11, arginine at position 13, and alanine at position 71 of HLA-DRbeta1. Surprisingly, we identified only residues preferentially expressed in the MS group that were related to HLA-DR2. Thus, the contribution of HLA class II to the pathogenesis of MS is not mediated by allele-overlapping antigen binding sites, but is confined to the disease associated HLA allele.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082515     DOI: 10.1016/s0198-8859(00)00173-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Authors:  Mireia Sospedra; Paolo A Muraro; Irena Stefanová; Yingdong Zhao; Katherine Chung; Yili Li; Marc Giulianotti; Richard Simon; Roy Mariuzza; Clemencia Pinilla; Roland Martin
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

3.  Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants.

Authors:  Jason H Karnes; Lisa Bastarache; Christian M Shaffer; Silvana Gaudieri; Yaomin Xu; Andrew M Glazer; Jonathan D Mosley; Shilin Zhao; Soumya Raychaudhuri; Simon Mallal; Zhan Ye; John G Mayer; Murray H Brilliant; Scott J Hebbring; Dan M Roden; Elizabeth J Phillips; Joshua C Denny
Journal:  Sci Transl Med       Date:  2017-05-10       Impact factor: 17.956

4.  An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene.

Authors:  Sreeram V Ramagopalan; Roisin McMahon; David A Dyment; A Dessa Sadovnick; George C Ebers; Knut M Wittkowski
Journal:  BMC Med Genet       Date:  2009-02-04       Impact factor: 2.103

5.  Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study.

Authors:  Amit Kumar; Eleonora Cocco; Luigi Atzori; Maria Giovanna Marrosu; Enrico Pieroni
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

6.  Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.

Authors:  Eleonora Cocco; Raffaele Murru; Gianna Costa; Amit Kumar; Enrico Pieroni; Cristina Melis; Luigi Barberini; Claudia Sardu; Lorena Lorefice; Giuseppe Fenu; Jessica Frau; Giancarlo Coghe; Nicola Carboni; Maria Giovanna Marrosu
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.